Blau JE - Search Results

1

SGLT2 Inhibitors May Predispose to Ketoacidosis.

Taylor SI, Blau JE, Rother KI. Taylor SI, et al. Among authors: blau je. J Clin Endocrinol Metab. 2015 Aug;100(8):2849-52. doi: 10.1210/jc.2015-1884. Epub 2015 Jun 18. J Clin Endocrinol Metab. 2015. PMID: 26086329 Free PMC article. Review.

2

Possible adverse effects of SGLT2 inhibitors on bone.

Taylor SI, Blau JE, Rother KI. Taylor SI, et al. Among authors: blau je. Lancet Diabetes Endocrinol. 2015 Jan;3(1):8-10. doi: 10.1016/S2213-8587(14)70227-X. Epub 2014 Dec 16. Lancet Diabetes Endocrinol. 2015. PMID: 25523498 Free PMC article. No abstract available.

3

Long-term immunosuppression after solitary islet transplantation is associated with preserved C-peptide secretion for more than a decade.

Blau JE, Abegg MR, Flegel WA, Zhao X, Harlan DM, Rother KI. Blau JE, et al. Am J Transplant. 2015 Nov;15(11):2995-3001. doi: 10.1111/ajt.13383. Epub 2015 Jul 16. Am J Transplant. 2015. PMID: 26184712 Free PMC article.

4

Nonnutritive Sweeteners in Breast Milk.

Sylvetsky AC, Gardner AL, Bauman V, Blau JE, Garraffo HM, Walter PJ, Rother KI. Sylvetsky AC, et al. Among authors: blau je. J Toxicol Environ Health A. 2015;78(16):1029-32. doi: 10.1080/15287394.2015.1053646. Epub 2015 Aug 12. J Toxicol Environ Health A. 2015. PMID: 26267522 Free PMC article.

5

Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research.

Sylvetsky AC, Blau JE, Rother KI. Sylvetsky AC, et al. Among authors: blau je. Rev Endocr Metab Disord. 2016 Jun;17(2):187-94. doi: 10.1007/s11154-016-9344-5. Rev Endocr Metab Disord. 2016. PMID: 26936185 Free PMC article. Review.

6

Hormonal responses to non-nutritive sweeteners in water and diet soda.

Sylvetsky AC, Brown RJ, Blau JE, Walter M, Rother KI. Sylvetsky AC, et al. Among authors: blau je. Nutr Metab (Lond). 2016 Oct 21;13:71. doi: 10.1186/s12986-016-0129-3. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27777606 Free PMC article.

7

Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data.

Blau JE, Tella SH, Taylor SI, Rother KI. Blau JE, et al. Diabetes Metab Res Rev. 2017 Nov;33(8):10.1002/dmrr.2924. doi: 10.1002/dmrr.2924. Epub 2017 Sep 29. Diabetes Metab Res Rev. 2017. PMID: 28736981 Free PMC article.

8

Plasma concentrations of sucralose in children and adults.

Sylvetsky AC, Bauman V, Blau JE, Garraffo HM, Walter PJ, Rother KI. Sylvetsky AC, et al. Among authors: blau je. Toxicol Environ Chem. 2017;99(3):535-542. doi: 10.1080/02772248.2016.1234754. Epub 2016 Oct 17. Toxicol Environ Chem. 2017. PMID: 28775393 Free PMC article.

9

Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.

Blau JE, Bauman V, Conway EM, Piaggi P, Walter MF, Wright EC, Bernstein S, Courville AB, Collins MT, Rother KI, Taylor SI. Blau JE, et al. JCI Insight. 2018 Apr 19;3(8):e99123. doi: 10.1172/jci.insight.99123. eCollection 2018 Apr 19. JCI Insight. 2018. PMID: 29669938 Free PMC article. Clinical Trial.

10

Adverse effects of SGLT2 inhibitors on bone health.

Blau JE, Taylor SI. Blau JE, et al. Nat Rev Nephrol. 2018 Aug;14(8):473-474. doi: 10.1038/s41581-018-0028-0. Nat Rev Nephrol. 2018. PMID: 29875481 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

39 results

Search Page